Jeff Fairman - Aug 4, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Aug 4, 2022
Transactions value $
-$383,508
Form type
4
Date filed
8/5/2022, 07:12 PM
Previous filing
May 24, 2022
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$255K -10K -3.11% $25.50 311K Aug 4, 2022 By Fairman Family Trust F1
transaction PCVX Common Stock Sale -$129K -5K -1.61% $25.70 306K Aug 5, 2022 By Fairman Family Trust F1, F2
holding PCVX Common Stock 17.7K Aug 4, 2022 Direct
holding PCVX Common Stock 50K Aug 4, 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.50 to $26.035. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.